A series of ER-positive, HER2-negative and triple negative localized breast cancers showed that presence of tumor budding was associated with worse OS in triple negative patients, while no prognostic value was discerned in ER-positive and HER2-negative patients [13]. This evidence concerns the gene ERBB2 and neoplasm.